The use of drugs and supplements to enhance performance has become a part of mainstream athletics. Many team physicians and sports medicine practitioners are unfamiliar with the benefits and risks of these products and thus are unable to educate young athletes on this topic. In spite of numerous reports on the health risks of anabolic steroid use, 1 to 3 million Americans have used them. Human growth hormone has been tried by up to 5% of 10th graders, although no scientific study has shown that it is an effective performance-enhancing drug. Amphetamines and similar compounds may be the most widely abused drug in baseball; recently, they have come under increased scrutiny in sport. Erythropoietin is a highly effective aerobic enhancer that has been linked to multiple deaths in cyclists and other endurance athletes. The neutraceutical industry, led by supplements such as creatine, ephedra, and androstenedione, remains unregulated by the Food and Drug Administration and has serious issues with quality and side effects. An understanding of these products is essential for the sports medicine practitioner to provide sound, safe advice to the athlete.
1. Aaserud R, Gramvik P, Olsen SR, et al. Creatine supplementation delays onset of fatigue during repeated bouts of sprint running. Scand J Med Sci Sports. 1998;8:247-251.
2.
2. Bahrke MS, Yesalis CE, Brower KJ. Anabolic-androgenic steroid abuse and performance-enhancing drugs among adolescents. Child Adolesc Psychiatr Clin N Am. 1998;7:821-838.
3.
3. Ballantyne CS, Phillips SM, MacDonald JR, et al. The acute effects of and rostenedione supplementation in healthy young males. Can J Appl Physiol. 2000;25:68-78.
4.
4. Balsom PD, Ekbolm B, Soderlund K, et al. Creatine supplementation and dynamic high-intensity intermittent exercise. Scand J Med Sci Sports. 1993;3:143-149.
5.
5. Balsom PD, Soderlund K, Ekblom B. Creatine in humans with special reference to creatine supplementation. Sports Med. 1994;18:268-280.
6.
6. Bamberger M, Yaeger D. Over the edge: special report. Sports Illustrated. 1997;86:64-64.
7.
7. Bell DG, Jacobs I. Combined caffeine and ephedrine ingestion improves run times of Canadian Forces Warrior Test. Aviat Space Environ Med. 1999;70:325-329.
8.
8. Bell DG, McLellan TM, Sabiston CM. Effect of ingesting caffeine and ephedrine on 10-km run performance. Med Sci Sports Exerc. 2002;34:344-349.
9.
9. Benzi G. Is there a rationale for the use of creatine either as nutritional supplementation or drug administration in humans participating in a sport?Pharmacol Res. 2000;41:255-264.
10.
10. Bhasin S, Storer TW, Berman N, et al. The effects of supraphysio-logic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335:1-7.
11.
11. Birch R, Noble D, Greenhaff PL. The influence of dietary creatine supplementation on performance during repeated bouts of maximal isokinetic cycling in man. Eur J Appl Physiol. 1994;69:268-276.
12.
12. Birkeland KI, Stray-Gundersen J, Hemmersbach P, et al. Effect of rhEPO administration on serum levels of sTfR and cycling performance. Med Sci Sports Exerc. 2000;32:1238-1243.
13.
13. Bowers LD. Analytical advances in detection of performance-enhancing compounds. Clin Chem. 1997;43:1299-1304.
14.
14. Broeder CE, Quindry J, Brittingham K, et al. The Andro Project: physiological and hormonal influences of androstenedione supplementation in men 35 to 65 years old participating in a high-intensity resistance training program. Arch Intern Med. 2000;160:3093-3104.
15.
15. Brown GA, Martini ER, Roberts BS, et al. Acute hormonal response to sublingual and rostenediol intake in young men. J Appl Physiol. 2002;92:142-146.
16.
16. Brown GA, Vukovich MD, Martini ER, et al. Endocrine and lipid responses to chronic androstenediol-herbal supplementation in 30 to 58 year old men. J Am Coll Nutr. 2001;20:520-528.
17.
17. Burke LM, Pyne DB, Telford RD. Effect of oral creatine supplementation on single-effort sprint performance in elite swimmers. Int J Sport Nutr. 1996;6:222-233.
18.
18. Cable NT. Anabolic-androgenic steroids: ergogenic and cardiovascular effects. In: Reilly T, Orme M, eds. The Clinical Pharmacology of Sport and Exercise. Amsterdam, the Netherlands: Exerpta Medica; 1997: 135-144.
19.
19. Carroll PV, Van den Berghe G. Safety aspects of pharmacological GH therapy in adults. Growth Horm IGF Res. 2001;11:166-172.
20.
20. Casey A, Constantin-Teodosiu D, Howell S, et al. Creatine ingestion favorably affects performance and muscle metabolism during maximal exercise in humans. Am J Physiol. 1996;271:E31-E37.
21.
21. Chandler JV, Blair SN. The effect of amphetamines on selected physiological components related to athletic success. Med Sci Sports Exerc. 1980;12:65-69.
22.
22. Conlee RK. Amphetamine, caffeine, and cocaine. In: Lamb DR, Williams MH, eds. Ergogenics: Enhancement of Performance in Exercise and Sport. Dubuque, Iowa: Brown and Benchmark; 1991:285-330.
23.
23. Cooper CJ, Noakes TD, Dunne T, et al. A high prevalence of abnormal personality traits in chronic users of anabolic-androgenic steroids. Br J Sports Med. 1996;30:246-250.
24.
24. Crist DM, Stackpole PJ, Peake GT. Effects of androgenic-anabolic steroids on neuromuscular power and body composition. J Appl Physiol. 1983;54:366-370.
25.
25. Curry LA, Wagman DF. Qualitative description of the prevalence and use of anabolic androgenic steroids by United States power-lifters. Percept Mot Skills. 1999;88:224-233.
26.
26. Dawson B, Cutler M, Moody A, et al. Effects of oral creatine loading on single and repeated maximal short sprints. Aust J Sci Med Sport. 1995;27:56-61.
27.
27. Earnest CP, Snell PG, Rodriguez R, et al. The effect of creatine monohydrate ingestion on anaerobic power indices, muscular strength and body composition. Acta Physiol Scand. 1995;153:207-209.
28.
28. Ebenbichler CF, Sturm W, Ganzer H, et al. Flow-mediated, endothelium-dependent vasodilatation is impaired in male body builders taking anabolic-androgenic steroids. Atherosclerosis. 2001;158:483-490.
30. Ekblom B, Berglund B. Effect of erythropoietin administration on maximal aerobic power. Scand J Med Sci Sports. 1991;1:88-93.
31.
31. Engelhardt M, Neumann G, Berbalk A, et al. Creatine supplementation in endurance sports. Med Sci Sports Exerc. 1998;7:1123-1129.
32.
32. Febbraio MA, Flanagan TR, Snow RJ, et al. Effect of creatine supplementation on intramuscular TCr, metabolism and performance during intermittent, supramaximal exercise in humans. Acta Physiol Scand. 1995;155:387-395.
33.
33. Fineschi V, Baroldi G, Monciotti F, et al. Anabolic steroid abuse and cardiac sudden death: a pathologic study. Arch Pathol Lab Med. 2001;125:253-255.
34.
34. Forbes GB, Porta CR, Herr BE, et al. Sequence of changes in body composition induced by testosterone and reversal of changes after drug is stopped. JAMA. 1992;267:397-399.
35.
35. Friedl KE, Dettori JR, Hannan CJ Jr, et al. Comparison of the effects of a high dose of testosterone and 19-nortestosterone to a replacement dose of testosterone on strength and body composition in normal men. J Steroid Biochem Mol Biol. 1991;40:607-612.
36.
36. Frisch H. Growth hormone and body composition in athletes. J Endocrinol Invest. 1999;22(suppl):106-109.
37.
37. Gallagher PM, Carrithers JA, Godard MP, et al. Beta-hydroxy-betamethylbutyrate ingestion, part I: effects on strength and fat free mass. Med Sci Sports Exerc. 2000;32:2109-2115.
38.
38. Gallagher PM, Carrithers JA, Godard MP, et al. Beta-hydroxy-betamethylbutyrate ingestion, part II: effects on hematology, hepatic and renal function. Med Sci Sports Exerc. 2000;32:2116-2119.
39.
39. Gill ND, Shield A, Blazevich AJ, et al. Muscular and cardiorespiratory effects of pseudoephedrine in human athletes. Br J Clin Pharmacol. 2000;50:205-213.
40.
40. Giorgi A, Weatherby RP, Murphy PW. Muscular strength, body composition, and health responses to the use of testosterone enanthate: a double blind study. J Sci Med Sport. 1999;2:341-355.
42. Greenhaff PL. Creatine and its application as an ergogenic aid. Int J Sport Nutr. 1995;5:S100-S110.
43.
43. Greenwood M, Farris J, Kreider R, et al. Creatine supplementation patterns and perceived effects in select Division I collegiate athletes. Clin J Sport Med. 2000;10:191-194.
44.
44. Grindstaff PD, Kreider R, Bishop R, et al. Effects of creatine supplementation on repetitive sprint performance and body composition in competitive swimmers. Int J Sport Nutr. 1997;7:330-346.
45.
45. Gruber AJ, Pope HG Jr. Ephedrine abuse among 36 female weightlifters. Am J Addict. 1998;7:256-261.
46.
46. Guerrero-Ontiveros ML, Wallimann T. Creatine supplementation in health and disease: effects of chronic creatine ingestion in vivo: down-regulation of the expression of creatine transporter isoforms in skeletal muscle. Mol Cell Biochem. 1998;184:427-437.
47.
47. Harris RC, Soderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci (Lond). 1992;83:367-374.
48.
48. Harris RC, Viru M, Greenhaff PL, et al. The effect of oral creatine supplementation on running performance during maximal short term exercise in man. J Physiol. 1993;74:467-469.
49.
49. Hartgens F, Kuipers H, Wijnen JA, et al. Body composition, cardiovascular risk factors and liver function in long-term and rogenicanabolic steroids using bodybuilders three months after drug withdrawal. Int J Sports Med. 1996;17:429-433.
50.
50. Javierre C, Lizarraga MA, Ventura JL, et al. Creatine supplementation does not improve physical performance in a 150 m race. Rev Esp Fisiol. 1997;53:343-348.
51.
51. Juhn MS, Tarnopolsky M. Potential side effects of oral creatine supplementation: a critical review. Clin J Sport Med. 1998;8:298-304.
52.
52. King DS, Sharp RL, Vukovich MD, et al. Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial. JAMA. 1999;281:2020-2028.
53.
53. Knitter AE, Panton L, Rathmacher JA, et al. Effects of beta-hydroxy-beta-methylbutyrate on muscle damage after a prolonged run. J Appl Physiol. 2000;89:1340-1344.
54.
54. Koshy KM, Griswold E, Schneeberger EE. Interstitial nephritis in a patient taking creatine. N Engl J Med. 1999;340:814-815.
55.
55. Kraemer WJ, Volek JS. Creatine supplementation: its role in human performance. Clin Sports Med. 1999;18:651-666, ix-ix.
56.
56. Kreider RB, Ferreira M, Wilson M, et al. Effects of calcium beta-hydroxy-beta-methylbutyrate (HMB) supplementation during resistance-training on markers of catabolism, body composition and strength. Int J Sports Med. 1999;20:503-509.
57.
57. Kuipers H, Wijnen JA, Hartgens F, et al. Influence of anabolic steroids on body composition, blood pressure, lipid profile, and liver functions in body builders. Int J Sports Med. 1991;12:413-418.
58.
58. LaBotz M, Smith BW. Creatine supplement use in an NCAA Division I athletic program. Clin J Sport Med. 1999;9:167-169.
59.
59. Lavoie C, Diguet A, Milot M, et al. Erythropoietin (rHuEPO) doping: effects of exercise on anaerobic metabolism in rats. Int J Sports Med. 1998;19:281-286.
60.
60. Leder BZ, Longcope C, Catlin DH, et al. Oral androstenedione administration and serum testosterone concentrations in young men. JAMA. 2000;283:779-782.
61.
61. Leenders NM, Lamb DR, Nelson TE. Creatine supplementation and swimming performance. Int J Sport Nutr. 1999;9:251-262.
62.
62. Macintyre JG. Growth hormone and athletes. Sports Med. 1987;4:129-142.
63.
63. MacKinnon DP, Goldberg L, Clarke GN, et al. Mediating mechanisms in a program to reduce intentions to use anabolic steroids and improve exercise self-efficacy and dietary behavior. Prev Sci. 2001;2:15-28.
64.
64. Melia P, Pipe A, Greenberg L. The use of anabolic-androgenic steroids by Canadian students. Clin J Sport Med. 1996;6:9-14.
65.
65. Middleman AB, DuRant RH. Anabolic steroid use and associated health risk behaviours. Sports Med. 1996;21:51-55.
66.
66. Midgley SJ, Heather N, Davies JB. Levels of aggression among a group of anabolic-androgenic steroid users. Med Sci Law. 2001;41:309-314.
67.
67. Mujika I, Chatard JC, Lacoste L, et al. Creatine supplementation does not improve sprint performance in competitive swimmers. Med Sci Sports Exerc. 1996;28:1435-1441.
68.
68. Mujika I, Padilla S, Ibanez J, et al. Creatine supplementation and sprint performance in soccer players. Med Sci Sports Exerc. 2000;32:518-525.
69.
69. Nilsson S, Baigi A, Marklund B, et al. Trends in the misuse of androgenic anabolic steroids among boys 16-17 years old in a primary health care area in Sweden. Scand J Prim Health Care. 2001;19:181-182.
70.
70. Nissen S, Sharp R, Ray M, et al. Effect of leucine metabolite beta-hydroxy-beta-methylbutyrate on muscle metabolism during resistance-exercise training. J Appl Physiol. 1996;81:2095-2104.
71.
71. Nissen S, Sharp RL, Panton L, et al. Beta-hydroxy-beta-methylbutyrate (HMB) supplementation in humans is safe and may decrease cardiovascular risk factors. J Nutr. 2000;130:1937-1945.
72.
72. Panton LB, Rathmacher JA, Baier S, et al. Nutritional supplementation of the leucine metabolite beta-hydroxy-beta-methylbutyrate (hmb) during resistance training. Nutrition. 2000;16:734-739.
73.
73. Papadimitriou A, Preece MA, Rolland-Cachera MF, et al. The anabolic steroid oxandrolone increases muscle mass in prepubertal boys with constitutional delay of growth. J Pediatr Endocrinol Metab. 2001;14:725-727.
74.
74. Parssinen M, Kujala U, Vartiainen E, et al. Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med. 2000;21:225-227.
76. Ramotar J. Cyclists’ deaths linked to erythropoietin?Phys Sportsmed. 1990;18:48-49.
77.
77. Rasmussen BB, Volpi E, Gore DC, et al. Androstenedione does not stimulate muscle protein anabolism in young healthy men. J Clin Endocrinol Metab. 2000;85:55-59.
78.
78. Redondo DR, Dowling EA, Graham BL, et al. The effect of oral creatine monohydrate supplementation on running velocity. Int J Sport Nutr. 1996;6:213-221.
79.
79. Rich JD, Dickinson BP, Feller A, et al. The infectious complications of anabolic-androgenic steroid injection. Int J Sports Med. 1999;20:563-566.
80.
80. Rich JD, Foisie CK, Towe CW, et al. Needle exchange program participation by anabolic steroid injectors, United States 1998. Drug Alcohol Depend. 1999;56:157-160.
81.
81. Rickert VI, Pawlak-Morello C, Sheppard V, et al. Human growth hormone: a new substance of abuse among adolescents?Clin Pediatr (Phila). 1992;31:723-726.
82.
82. Rico-Sanz J, Mendez Marco MT. Creatine enhances oxygen uptake and performance during alternating intensity exercise. Med Sci Sports Exerc. 2000;32:379-385.
83.
83. Sattler FR, Jaque SV, Schroeder ET, et al. Effects of pharmacologic doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus. J Clin Endocrinol Metab. 1999;84:1268-1276.
84.
84. Sawka MN, Joyner MJ, Miles DS, et al. American College of Sports Medicine position stand: the use of blood doping as an ergogenic aid. Med Sci Sports Exerc. 1996;28:i-viii.
85.
85. Schedel JM, Terrier P, Schutz Y. The biomechanic origin of sprint performance enhancement after one-week creatine supplementation. Jpn J Physiol. 2000;50:273-276.
86.
86. Shahidi NT. A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. Clin Ther. 2001;23:1355-1390.
87.
87. Silber ML. Scientific facts behind creatine monohydrate as sport nutrition supplement. J Sports Med Phys Fitness. 1999;39:179-188.
88.
88. Silver MD. Use of ergogenic aids by athletes. J Am Acad Orthop Surg. 2001;9:61-70.
89.
89. Slater GJ, Logan PA, Boston T, et al. Beta-hydroxy-beta-methylbutyrate (HMB) supplementation does not influence the urinary testosterone: epitestosterone ratio in healthy males. J Sci Med Sport. 2000;3:79-83.
90.
90. Smith SA, Montain SJ, Matott RP, et al. Creatine supplementation and age influence muscle metabolism during exercise. J Appl Physiol. 1998;85:1349-1356.
91.
91. Snyder PJ, Peachey H, Hannoush P, et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab. 1999;84:2647-2653.
92.
92. Stilger VG, Yesalis CE. Anabolic-androgenic steroid use among high school football players. J Community Health. 1999;24:131-145.
93.
93. Stone MH, Sanborn K, Smith LL, et al. Effects of in-season (5 weeks) creatine and pyruvate supplementation on anaerobic performance and body composition in American football players. Int J Sport Nutr. 1999;9:146-165.
94.
94. Sullivan ML, Martinez CM, Gennis P, et al. The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis. 1998;41:1-15.
95.
95. Taaffe DR, Pruitt L, Reim J, et al. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. J Clin Endocrinol Metab. 1994;79:1361-1366.
96.
96. Thiblin I, Lindquist O, Rais J. Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci. 2000;45:16-23.
97.
97. Todhunter EN. Chronology of some events in the development and application of the science of nutrition. Nutr Rev. 1976;34:353-365.
98.
98. Videman T, Lereim I, Hemmingsson P, et al. Changes in hemoglobin values in elite cross-country skiers from 1987-1999. Scand J Med Sci Sports. 2000;10:98-102.
99.
99. Vukovich MD, Dreifort GD. Effect of beta-hydroxy beta-methylbutyrate on the onset of blood lactate accumulation and V(O) (2) peak in endurance-trained cyclists. J Strength Cond Res. 2001;15:491-497.
100.
100. Wallace MB, Lim J, Cutler A, et al. Effects of dehydroepiandrosterone vs androstenedione supplementation in men. Med Sci Sports Exerc. 1999;31:1788-1792.
101.
101. Williams MH, Branch JD. Ergogenic aids for improved performance. In: Garrett WE, Kirkendall DT, eds. Exercise and Sport Science. Philadelphia, Pa: Lippincott, Williams and Wilkins; 2000:373-384.
102.
102. Yarasheski KE. Growth hormone effects on metabolism, body composition, muscle mass, and strength. Exerc Sport Sci Rev. 1994;22:285-312.
